Searchable abstracts of presentations at key conferences in endocrinology

ea0081p623 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Metabolic Syndrome (MetS) Criteria in children with steroid-sensitive Nephrotic syndrome (SSNS) and frequent relapses treated with long-term prednisone therapy (LTPT) vs normal obese children

Soliman Ashraf , Elbaba Mostafa , Hamed Noor , Dalees Mona Shaat , Itani Maya , Al-Naimi Fatima

Steroid-associated adverse events (SAAE) include hypertension, hyperglycemia, and diabetes, overweight and obesity and short stature.Aim: The goal of this study was to assess the occurrence of steroid-associated metabolic and clinical adverse events (SAAE) in patients with NS and frequent relapses treated with long-term prednisone compared to another high-risk group (obese children BMISDS > 2)Methods: Data of 30 children with S...

ea0081p605 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The effects of Long-term (five years) prednisone therapy in frequently relapsing nephrotic syndrome of childhood: impact on glycemia and the different components of the metabolic syndrome (MetS)

Elbaba Mostafa , Hamed Noor , Soliman Ashraf , Alyafei Fawzia , Itani Maya , Al-Naimi Fatima , Al Yousef Doaa , Dalees Mona Shaat

Although widely prescribed for their anti-inflammatory and immunosuppressive properties, glucocorticoids have various common metabolic side effects including hypertension, dysglycemia and diabetes. Aim: This study was carried out to investigate the prevalence of different metabolic components and dysglycemia in children with steroid sensitive nephrotic syndrome (SSNS) with multiple relapses for 5 years in relation to the cumulative dose of steroids.<...

ea0081ep327 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Growth Assessment and Metabolic Syndrome (MetS) Criteria in children with steroid-sensitive Nephrotic syndrome (SSNS) and frequent relapses treated with long-term prednisone therapy (LTPT): Comparison between children who developed obesity versus those who did not develop obesity

Elbaba Mostafa , Soliman Ashraf , Hamed Noor , Alyafei Fawzia , Itani Maya , Al-Naimi Fatima , Al Yousef Doaa , Shaat Dalees Mona

Introduction: Long term prednisone therapy (LTPT) can be associated with overweight, obesity, and short stature. Both LTPT and obesity are considered risk factor for the occurrence of the different components of the metabolic syndrome (MetS).Aim: We studied steroid-associated metabolic and clinical adverse events in children with NS and frequent relapses treated with LTPT (obese vs non-obese). Methods: Data of 30 children with SSNS...

ea0081ep376 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The growth effects of long-term (five years) prednisone therapy in frequently relapsing nephrotic syndrome of childhood: impact on statural growth and weight gain

Soliman Ashraf , Hamed Noor , Elbaba Mostafa , Alyafei Fawzia , Itani Maya , Al-Naimi Fatima , Al Yousef Doaa , Shaat Dalees Mona

Nephrotic syndrome (NS) in children usually has an onset between 2-8 years of age and steroids form the mainstay of management. Therapy may affect growth in children with relapsing NS.Aim: This study was carried out to investigate linear growth and weigh gain in children with NS and multiple relapses who receiving long-term prednisone therapy (LTPT) for 5 years.Methods: Data of 30 children with SSNS was analysed retrospectively. Th...